ROCKVILLE, Md., June 2, 2011 /PRNewswire/ — Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ:
VNDA), a biopharmaceutical company focused on the development
and commercialization of products for central nervous system
disorders, today announced that Mihael H. Polymeropoulos, M.D.,
Vanda President and CEO will deliver a corporate presentation on
Thursday, June 9, at 8:30 a.m. Eastern Time.
The presentation will take place as part of the Jefferies 2011
Global Healthcare Conference in New York, New York. Dr.
Polymeropoulos’ remarks will be available live on the Vanda
Website, where it also will be archived for 90 days.
To access the presentation, log on to http://www.vandapharma.com
and click on the Presentations option in the Investor Relations
section. Please connect to the website several minutes prior to the
start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of products for
central nervous system disorders. For more on Vanda Pharmaceuticals
Inc., please visit http://www.vandapharma.com.
Company Contact:
Cristina Murphy
Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
cristina.murphy@vandapharma.com
‘/>”/>
SOURCE
